P

PainReform Ltd
D

PRFX

3.16000
USD
-0.28
(-8.14%)
مغلق
حجم التداول
3,818
الربح لكل سهم
-48
العائد الربحي
-
P/E
-0
حجم السوق
2,764,564
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: PainReform Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.